Literature DB >> 27347346

Overexpression of long non-coding RNA HOTTIP increases chemoresistance of osteosarcoma cell by activating the Wnt/β-catenin pathway.

Zhenwei Li1, Liang Zhao1, Qiugen Wang2.   

Abstract

Long non-coding RNAs (lncRNAs) have been identified as oncogenes or tumor suppressors that are involved in tumorigenesis and chemotherapy resistance. HOTTIP is located at the 5' tip of the HOXA locus and coordinates the activation of multiple 5' HOXA genes, which plays an important role in multiple cancers. However, its biological role in the development of the chemoresistance phenotype of osteosarcoma (OS) is still unknown. In this study, we explored the roles of lncRNA HOTTIP in the initiation and chemoresistance of OS. We found that HOTTIP was increased in OS and up-regulated expression of HOTTIP could promoted OS cell proliferation and cell cycle progression by activating the Wnt/β-catenin pathway. Down-regulated expression of HOTTIP inhibited cell proliferation and arrested cell cycle at G1 phase by inhibition of Wnt/β-catenin pathway. Furthermore, our data showed that increased expression of HOTTIP was correlated with chemoresistance in OS. In vitro, HOTTIP induced cellular resistance to cisplatin by activating the Wnt/β-catenin pathway, which could be reversed by treatment with the Wnt/β-catenin inhibitor. Taken together, these findings indicated that HOTTIP play a pivotal role in OS cell initiation and chemoresistance via activating Wnt/β-catenin signaling pathway, which suggested potential use of HOTTIP for the treatment of osteosarcoma.

Entities:  

Keywords:  HOTTIP; Osteosarcoma; Wnt/β-catenin; chemoresistance; proliferation

Year:  2016        PMID: 27347346      PMCID: PMC4891451     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  20 in total

Review 1.  Non-coding RNAs in human disease.

Authors:  Manel Esteller
Journal:  Nat Rev Genet       Date:  2011-11-18       Impact factor: 53.242

2.  Long none coding RNA HOTTIP/HOXA13 act as synergistic role by decreasing cell migration and proliferation in Hirschsprung disease.

Authors:  Hua Xie; Dongmei Zhu; Cao Xu; Hairong Zhu; Pingfa Chen; Hongxing Li; Xiang Liu; Yankai Xia; Weibing Tang
Journal:  Biochem Biophys Res Commun       Date:  2015-06-02       Impact factor: 3.575

Review 3.  Molecular mechanisms of long noncoding RNAs.

Authors:  Kevin C Wang; Howard Y Chang
Journal:  Mol Cell       Date:  2011-09-16       Impact factor: 17.970

4.  Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients.

Authors:  Luca Quagliata; Matthias S Matter; Salvatore Piscuoglio; Leila Arabi; Christian Ruiz; Alfredo Procino; Michal Kovac; Francesca Moretti; Zuzanna Makowska; Tujana Boldanova; Jesper B Andersen; Monika Hämmerle; Luigi Tornillo; Markus H Heim; Sven Diederichs; Clemente Cillo; Luigi M Terracciano
Journal:  Hepatology       Date:  2014-01-28       Impact factor: 17.425

Review 5.  Enhancer function: new insights into the regulation of tissue-specific gene expression.

Authors:  Chin-Tong Ong; Victor G Corces
Journal:  Nat Rev Genet       Date:  2011-03-01       Impact factor: 53.242

6.  Osteosarcoma of the jaws: a 30-year retrospective review.

Authors:  J H Bennett; G Thomas; A W Evans; P M Speight
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2000-09

Review 7.  Osteosarcoma: a multidisciplinary approach to diagnosis and treatment.

Authors:  James C Wittig; Jacob Bickels; Dennis Priebat; James Jelinek; Kristen Kellar-Graney; Barr Shmookler; Martin M Malawer
Journal:  Am Fam Physician       Date:  2002-03-15       Impact factor: 3.292

Review 8.  Wnt/beta-catenin signaling pathway as a novel cancer drug target.

Authors:  Hue H Luu; Ruiwen Zhang; Rex C Haydon; Elizabeth Rayburn; Quan Kang; Weike Si; Jong Kyung Park; Hui Wang; Ying Peng; Wei Jiang; Tong-Chuan He
Journal:  Curr Cancer Drug Targets       Date:  2004-12       Impact factor: 3.428

9.  Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program.

Authors:  Lisa Mirabello; Rebecca J Troisi; Sharon A Savage
Journal:  Cancer       Date:  2009-04-01       Impact factor: 6.860

10.  GENCODE: the reference human genome annotation for The ENCODE Project.

Authors:  Jennifer Harrow; Adam Frankish; Jose M Gonzalez; Electra Tapanari; Mark Diekhans; Felix Kokocinski; Bronwen L Aken; Daniel Barrell; Amonida Zadissa; Stephen Searle; If Barnes; Alexandra Bignell; Veronika Boychenko; Toby Hunt; Mike Kay; Gaurab Mukherjee; Jeena Rajan; Gloria Despacio-Reyes; Gary Saunders; Charles Steward; Rachel Harte; Michael Lin; Cédric Howald; Andrea Tanzer; Thomas Derrien; Jacqueline Chrast; Nathalie Walters; Suganthi Balasubramanian; Baikang Pei; Michael Tress; Jose Manuel Rodriguez; Iakes Ezkurdia; Jeltje van Baren; Michael Brent; David Haussler; Manolis Kellis; Alfonso Valencia; Alexandre Reymond; Mark Gerstein; Roderic Guigó; Tim J Hubbard
Journal:  Genome Res       Date:  2012-09       Impact factor: 9.043

View more
  55 in total

Review 1.  Emerging roles of non-coding RNAs in the pathogenesis, diagnosis and prognosis of osteosarcoma.

Authors:  Chongchong Wang; Juehua Jing; Li Cheng
Journal:  Invest New Drugs       Date:  2018-08-06       Impact factor: 3.850

2.  Long non-coding RNA ZFAS1 sponges miR-484 to promote cell proliferation and invasion in colorectal cancer.

Authors:  Shuping Xie; Quanxing Ge; Xueyan Wang; Xinfang Sun; Yuhua Kang
Journal:  Cell Cycle       Date:  2018-01-17       Impact factor: 4.534

3.  LncRNA ODRUL Contributes to Osteosarcoma Progression through the miR-3182/MMP2 Axis.

Authors:  Kun-Peng Zhu; Xiao-Long Ma; Chun-Lin Zhang
Journal:  Mol Ther       Date:  2017-07-05       Impact factor: 11.454

Review 4.  Long Noncoding RNA and Cancer: A New Paradigm.

Authors:  Arunoday Bhan; Milad Soleimani; Subhrangsu S Mandal
Journal:  Cancer Res       Date:  2017-07-12       Impact factor: 12.701

5.  MDIG promotes cisplatin resistance of lung adenocarcinoma by regulating ABC transporter expression via activation of the WNT/β-catenin signaling pathway.

Authors:  Qing Wang; Feng Geng; Haomin Zhou; Yecheng Chen; Juan Du; Xinyu Zhang; Dandan Song; Hongwen Zhao
Journal:  Oncol Lett       Date:  2019-08-22       Impact factor: 2.967

6.  Long non-coding RNA CASC15 promotes tongue squamous carcinoma progression through targeting miR-33a-5p.

Authors:  Zhibin Zuo; Long Ma; Zuode Gong; Lande Xue; Qibao Wang
Journal:  Environ Sci Pollut Res Int       Date:  2018-05-26       Impact factor: 4.223

7.  Long noncoding RNA ATB promotes osteosarcoma cell proliferation, migration and invasion by suppressing miR-200s.

Authors:  Feng Han; Changhe Wang; Yi Wang; Liang Zhang
Journal:  Am J Cancer Res       Date:  2017-04-01       Impact factor: 6.166

8.  Chemotherapy-Induced Long Non-coding RNA 1 Promotes Metastasis and Chemo-Resistance of TSCC via the Wnt/β-Catenin Signaling Pathway.

Authors:  Zhaoyu Lin; Lijuan Sun; Shule Xie; Shanyi Zhang; Song Fan; Qunxing Li; Weixiong Chen; Guokai Pan; Weiwei Wang; Bin Weng; Zhang Zhang; Bodu Liu; Jinsong Li
Journal:  Mol Ther       Date:  2018-04-05       Impact factor: 11.454

Review 9.  Long Non-coding RNAs in Cisplatin Resistance in Osteosarcoma.

Authors:  Valeria A Ferretti; Ignacio E León
Journal:  Curr Treat Options Oncol       Date:  2021-03-20

10.  Circular RNA hsa_circ_0001649 suppresses the growth of osteosarcoma cells via sponging multiple miRNAs.

Authors:  Deping Sun; Dongsheng Zhu
Journal:  Cell Cycle       Date:  2020-09-20       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.